National Institute for Health and Care Excellence (NICE). Menopause: diagnosis and management: NICE Guideline. [NG 23] 2015, www.nice.org.uk/guidance/ng23 (accessed 1 December 2021).
National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summaries (CKS): Menopause 2020. London, UK: NICE, https://cks.nice.org.uk/topics/menopause (accessed 19 December 2021).
MacLennanAHBroadbentJLLesterS, et al.Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev2004 (4), Art. No.: CD002978. DOI: 10.1002/14651858.CD002978.pub2, www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002978.pub2/full (accessed 19 December 2021).
Electronic Medicines Compendium. Summary of Product Characteristics: Oestrogel Pump-Pack 750. Rue du Gabian, Monaco: Besins Healthcare Ltd. Micrograms/actuation Gel [estradiol], www.medicines.org.uk/emc/product/353/smpc (accessed 2 December 2021).
15.
Electronic Medicines Compendium. Summary of Product Characteristics: Utrogestan 100mg Capsules [Micronized Progesterone]. Rue du Gabian, Monaco: Besins Healthcare Ltd., www.medicines.org.uk/emc/product/352/smpc (accessed 2 December 2021).
16.
MacGregorE. A.Migraine, menopause and hormone replacement therapy. Post Reprod Health2018; 24(1): 11–18, DOI: 10.1177/2053369117731172 (accessed 2 December 2021).
AegidiusKLZwartJ-AHagenK, et al.Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol2007; 14: 73–78.
19.
MuellerL. Predictability of exogenous hormone effect on subgroups of migraineurs. Headache: J Head Face Pain2000; 40: 189–193.
Electronic Medicines Compendium. Summary of Product Characteristics: Imigran Injection. Subject [sumatriptan]. GlaxoSmithKline., www.medicines.org.uk/emc/medicine/749 (accessed 6 December 2021).
23.
National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summaries (CKS): Hypothyroidism 2021, https://cks.nice.org.uk/topics/hypothyroidism (accessed 2 December 2021).